Form 8-K - Current report:
SEC Accession No. 0001104659-24-010015
Filing Date
2024-02-02
Accepted
2024-02-02 16:01:27
Documents
15
Period of Report
2024-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244739d1_8k.htm   iXBRL 8-K 27351
2 EXHIBIT 10.1 tm244739d1_ex10-1.htm EX-10.1 66118
  Complete submission text file 0001104659-24-010015.txt   282915

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA swtx-20240131.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20240131_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20240131_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT tm244739d1_8k_htm.xml XML 3509
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 24591230
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)